| __timestamp | Dynavax Technologies Corporation | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 406114000 |
| Thursday, January 1, 2015 | 22180000 | 449119000 |
| Friday, January 1, 2016 | 37257000 | 502892000 |
| Sunday, January 1, 2017 | 27367000 | 544156000 |
| Monday, January 1, 2018 | 64770000 | 683530000 |
| Tuesday, January 1, 2019 | 74986000 | 736942000 |
| Wednesday, January 1, 2020 | 79256000 | 854233000 |
| Friday, January 1, 2021 | 100156000 | 1451683000 |
| Saturday, January 1, 2022 | 131408000 | 1416967000 |
| Sunday, January 1, 2023 | 152946000 | 1343105000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, operational efficiency is paramount. Jazz Pharmaceuticals plc and Dynavax Technologies Corporation, two prominent players, showcase contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade.
From 2014 to 2023, Jazz Pharmaceuticals consistently reported higher SG&A expenses, peaking at approximately $1.45 billion in 2021. This represents a staggering 257% increase from their 2014 figures. In contrast, Dynavax Technologies, while starting with significantly lower expenses, saw a dramatic rise of 760% over the same period, reaching around $153 million in 2023.
These trends highlight Jazz's expansive operational scale, while Dynavax's rapid growth reflects its aggressive market strategies. Understanding these dynamics offers valuable insights into each company's strategic priorities and market positioning.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dynavax Technologies Corporation or BioCryst Pharmaceuticals, Inc.